Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-ART-55460
J Pharmacol Sci 2018 Dec 01;1384:279-283. doi: 10.1016/j.jphs.2018.10.008.
Show Gene links Show Anatomy links

Inhibitory effects of Kampo medicines, Keishibukuryogan and Shakuyakukanzoto, on the substrate uptake activities of solute carrier organic anion transporters.

Lee HS , Shin HJ , Cho M , Lee SH , Oh DS .


???displayArticle.abstract???
The aim of this study was to assess the effects of Keishibukuryogan (K-06) and Shakuyakukanzoto (TJ-68), commercial herbal medicines, on the substrate uptake activities of renal organic anion transporters. We performed transporter uptake and cell viability assays in Xenopus oocytes and HEK293 human kidney embryonic cells treated with K-06 or TJ-68. K-06 and TJ-68 markedly inhibited the substrate uptake activities of URAT1, OAT1, and OAT3, while they did not exhibit non-cytotoxic effects. Our findings demonstrated that K-06 and TJ-68 inhibited the substrate uptake activities of renal transporters, suggesting their mechanism of action as nephroprotective agents.

???displayArticle.pubmedLink??? 30424926
???displayArticle.link??? J Pharmacol Sci


Species referenced: Xenopus
Genes referenced: kcnk3
GO keywords: anion transmembrane transport